Details for New Drug Application (NDA): 209900
✉ Email this page to a colleague
The generic ingredient in KETOROLAC TROMETHAMINE is ketorolac tromethamine; phenylephrine hydrochloride. There are eighteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the ketorolac tromethamine; phenylephrine hydrochloride profile page.
Summary for 209900
Tradename: | KETOROLAC TROMETHAMINE |
Applicant: | Baxter Hlthcare Corp |
Ingredient: | ketorolac tromethamine |
Patents: | 0 |
Pharmacology for NDA: 209900
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 209900
Suppliers and Packaging for NDA: 209900
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 209900 | ANDA | Baxter Healthcare Corporation | 0338-0069 | 0338-0069-10 | 10 VIAL in 1 CARTON (0338-0069-10) / 1 mL in 1 VIAL |
KETOROLAC TROMETHAMINE | ketorolac tromethamine | INJECTABLE;INJECTION | 209900 | ANDA | Baxter Healthcare Corporation | 0338-0072 | 0338-0072-25 | 25 VIAL in 1 CARTON (0338-0072-25) / 1 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 30MG/ML | ||||
Approval Date: | Sep 15, 2017 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 15MG/ML | ||||
Approval Date: | Jul 25, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription